Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Estrogen-progestagen therapy in the management of the polycystic ovary syndrome.

× No keyword cloud information.

30 in total

1. Relevance of biological properties of progestogen of oral contraceptives in treatment of androgen excess symptoms.

Authors: S Pang
Journal: J Clin Endocrinol Metab Date: 1990-07 Impact factor: 5.958

Review 2. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

Authors: D A Ehrmann; R B Barnes; R L Rosenfield
Journal: Endocr Rev Date: 1995-06 Impact factor: 19.871

Review 3. Gonadotropin-releasing hormone: role of pulsatile secretion in the regulation of reproduction.

Authors: J C Marshall; R P Kelch
Journal: N Engl J Med Date: 1986-12-04 Impact factor: 91.245

4. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.

Authors: C L Pastor; M L Griffin-Korf; J A Aloi; W S Evans; J C Marshall
Journal: J Clin Endocrinol Metab Date: 1998-02 Impact factor: 5.958

5. Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome?

Authors: A Dunaif
Journal: J Clin Endocrinol Metab Date: 1986-07 Impact factor: 5.958

6. Continuous gonadotropin-releasing hormone for ovulation induction in polycystic ovarian disease.

Authors: B G Stuckey; E J Keogh; P T Pullan; J A Beilby; R I Thompson; D V Evans
Journal: Fertil Steril Date: 1987-12 Impact factor: 7.329

7. The frequency of gonadotropin-releasing-hormone stimulation differentially regulates gonadotropin subunit messenger ribonucleic acid expression.

Authors: A C Dalkin; D J Haisenleder; G A Ortolano; T R Ellis; J C Marshall
Journal: Endocrinology Date: 1989-08 Impact factor: 4.736

Review 8. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors: A Dunaif
Journal: Endocr Rev Date: 1997-12 Impact factor: 19.871

9. Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulation.

Authors: S L Berga; D S Guzick; S J Winters
Journal: J Clin Endocrinol Metab Date: 1993-10 Impact factor: 5.958

10. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.

Authors: D de Ziegler; K Steingold; M Cedars; J K Lu; D R Meldrum; H L Judd; R J Chang
Journal: J Clin Endocrinol Metab Date: 1989-06 Impact factor: 5.958